Product image of Minirin (Desmopressin) supplied by GNH India

Minirin

Active Ingredient:
Desmopressin
Origin:
EU

Minirin (Desmopressin)

Desmopressin, the active ingredient in Minirin, is a antidiuretic (vasopressin analog) presented as a sublingual tablet for sublingual use. It treats central diabetes insipidus, nocturnal enuresis, and is used as adjunct therapy in hemophilia A and von Willebrand disease.

GNH India supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ferring Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Desmopressin is a synthetic vasopressin analog that acts on the antidiuretic pathway to reduce urine output and increase coagulation factor levels.

  • Central diabetes insipidus: reduces excessive urine production by enhancing renal water reabsorption.
  • Nocturnal enuresis: decreases nighttime bedwetting episodes by concentrating urine.
  • Hemophilia A (as adjunct therapy): raises plasma factor VIII levels to support clot formation.
  • von Willebrand disease (as adjunct therapy): increases von Willebrand factor to improve platelet adhesion.

How It Works

  • Desmopressin selectively stimulates V2 receptors on renal collecting‑duct cells, promoting insertion of aquaporin‑2 water channels and thereby increasing water reabsorption. The same V2 activation in endothelial cells elevates plasma factor VIII and von Willebrand factor, enhancing haemostatic capacity.

Side Effects

Desmopressin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Headache
  • Nausea
  • Mild throat irritation
  • Abdominal discomfort

Serious or Rare Side Effects

  • Severe hyponatraemia
  • Seizures
  • Allergic reactions such as rash or angioedema
  • Water intoxication leading to cerebral oedema

Precautions & Warnings

Before prescribing Minirin, clinicians should consider several safety aspects.

  • Renal function: assess in patients with impaired kidney function.
  • Electrolytes: monitor serum sodium regularly, especially in the elderly.
  • Fluid intake: limit excessive water consumption to avoid hyponatraemia.
  • Concomitant drugs: avoid use with other antidiuretic agents.
  • Pregnancy and lactation: safety not established; use only if benefit outweighs risk.
  • Store at below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Desmopressin can interact with several medicines, requiring careful management.

Major Interactions (Avoid)

  • Co‑administration with other vasopressin analogues or ADH agonists: risk of profound hyponatraemia.
  • Concurrent use of carbamazepine: may diminish antidiuretic effect.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may potentiate antidiuretic activity, monitor sodium levels.
  • Thiazide diuretics: increase risk of hyponatraemia.
  • Selective serotonin reuptake inhibitors (SSRIs): additive hyponatraemia risk.

Frequently Asked Questions

Minirin (desmopressin) is prescribed for central diabetes insipidus to reduce excessive urine output, for nocturnal enuresis to lessen nighttime bedwetting, and as an adjunct in hemophilia A and von Willebrand disease to raise clotting factor levels.

Desmopressin acts as a selective V2‑receptor agonist. In the kidneys it promotes aquaporin‑2 channel insertion, increasing water reabsorption. In endothelial cells it stimulates release of factor VIII and von Willebrand factor, enhancing haemostasis.

The dose of Minirin is individualized by the prescribing clinician based on the specific indication, patient age, weight, renal function and response to therapy. No universal dosing regimen is provided in product literature.

Safety data for desmopressin in pregnancy and lactation are limited. It is classified as pregnancy category unknown, so it should only be used when the potential benefit justifies any possible risk to the fetus or infant.

To order Minirin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with natural vasopressin, desmopressin has a longer half‑life and greater selectivity for V2 receptors, offering prolonged antidiuretic effect with fewer vasoconstrictive (V1) actions. It is also more convenient as a sublingual tablet versus injectable vasopressin.

Minirin tablets should be stored at temperatures below 25 °C, in their original packaging, and protected from moisture and direct sunlight to maintain stability and potency.

The sublingual tablet is placed under the tongue and allowed to dissolve completely without drinking water. Patients should remain upright for several minutes to ensure optimal absorption.

The most critical risks include severe hyponatraemia, which can lead to seizures or cerebral oedema, and water intoxication. Prompt monitoring of serum sodium and fluid intake is essential to mitigate these hazards.

Minirin is contraindicated in patients with existing hyponatraemia, uncontrolled fluid intake, severe renal impairment, or known hypersensitivity to desmopressin. Caution is also advised for individuals on interacting medications that affect sodium balance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.